3 Recruiting Studies Using Yl201
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Yl201
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
📍 City of Hope Orange County Lennar Foundation Cancer Center — Irvine, California
Small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of YL201 in Patients With Advanced Solid Tumors
📍 002 — Fair Oaks, California
Advanced Solid Tumor
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
📍 Site 1001 — Washington D.C., District of Columbia
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
View Study & Checklist ➔